PRECIGEN, INC.
Company Stats
- Market Cap
- $3.1B
- as of Sep 30, 2026
- Enterprise Value
- $3.1B
- Shares Outstanding
- 358.0M
- Free Float
- 59.7%
Income Statement
- Revenue
- $9.7M
- Operating Income
- -$110.5M
- Net Income
- -$250.6M
- EBITDA
- -$107.3M
- Non-cash Impairment
- $3.9M
- Revenue Growth, 3Y
- -28.9%
- FCF Margin, 3Y Avg
- -1327.7%
- FCF Margin, Worst Year
- -1955.6%
Cash Flow
- Free Cash Flow
- -$89.8M
- FCF Yield
- -2.9%
- Owner FCF Yield
- -3.3%
Balance Sheet
- Cash & Equivalents
- $30.2M
- Total Debt
- $100.0M
- Net Debt
- $69.8M
Returns & Capital
- SBC, 3Y Avg
- $10.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $9.7M | -$89.8M | -927.6% |
| FY2024 | $3.9M | -$76.8M | -1955.6% |
| FY2023 | $6.2M | -$68.5M | -1099.9% |
| FY2022 | $26.9M | -$70.0M | -260.0% |
| FY2021 | $14.3M | -$63.0M | -441.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back
Small Caps Leverage Pricing Power Amidst Input Volatility